asa guidelines for glp 1 Holding GLP-1 Agonists Prior to Elective Procedures Perioperative management of patients taking
Description
Those who persisted saw an average of 11% weight loss with semaglutide, and 13% with tirzepatide, outcomes similar to what's been shown in clinical trials

Then Mounjaro (tirzepatide) is the most potent among the three

Orforglipron is different from all existing GLP-1 drugs because it is a small molecule, not a peptide

Mudaliar S, Chang AR, Henry RR

Gelfand, Meghan C